16
Participants
Start Date
November 21, 2019
Primary Completion Date
February 28, 2021
Study Completion Date
NPC-06
Infuse NPC-06 intravenously
Kawasaki Hospital, Okayama
Lead Sponsor
Nobelpharma
INDUSTRY